Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
'Stranger Things' made him a heartthrob. He left Hollywood anyway. - 2Selena Quintanilla documentary 'Selena y Los Dinos: A Family's Legacy' is coming to Netflix
- 3The Solution to Innovative Peculiarity: Analyzing the Fate of Mankind
- 4Former 'Bachelorette' welcomes 1st baby via emergency c-section
- 5Don't miss these five impressive spots in Bangkok
- Israel has clear objectives south of Litani River, but will face difficult choices further north
- I visited the largest collection of public telescopes in the US in Oregon's high desert, and the dark skies blew me away
- Mechanical Sidekick d: A Survey of \Elements and Execution d\ Cell phone
- US FDA unveils new pathway to approve personalized therapies
- Video Conferencing Instruments for Virtual Gatherings
- There’s ‘super flu,’ COVID, RSV. Is it going around in SoCal?
- How food assistance programs can feed families and nourish their dignity
- New hybrid mpox strain discovered in UK after US reports local spread
- Jeff Bezos’ Blue Origin launches landmark Mars mission in New Glenn rocket’s first big test
